although there is little evidence that microbiota alters vaccine efficacy further understanding of human immune system-microbiota interactions may lead to the effective development of adjuvants and vaccines for the treatment of diseases.immune network 201717120-24keywords microbiota vaccine mucosal adjuvantintroductionthe human gut harbors trillions of bacteria that contribute to host physiological and immunological functions such as nutrient acquisition maintenance of the gut immune system and protection against exogenous pathogens 1- 3. one of the recent notable findings is the contribution of gut microbiota to the development and homeostasis of the immune system 13. the effects of microbiota on the host immune system have been determined by studies in germ-free gf animals 45. gf mice showed reduced numbers and size of peyer's patches 5 less lamina propria cd4 t cells 6 reduced levels of the class-switched antibodies iga and igg 78 and they lacked a developed gut-associated lymphoid tissue 910. thus maturation of the gut immune system generally takes place following the colonization of gut microbiotasuggesting a mutual relationship between the immune system and the microbiota.the gut microbiota consists of bacterial components and metabolites both of which are important for the development and maintenance of the host immune system.

6 832-837.seekatz a. m. a. panda d. a. rasko f. r. toapanta e. a. eloe-fadrosh a. q. khan z. liu s. t. shipley l. j. detollam.

plos one 7 e44763.smolen k. k. c. e. ruck e. s. fortuno iii k. ho p. dimitriu w. w. mohn d. p. speert p. j. cooper m. esser t. goetghebuer a. marchant and t. r. kollmann.

32 21- 27.nakaya h. i. j. wrammert e. k. lee l. racioppi s. marie- kunze w. n. haining a. r. means s. p. kasturi n. khang.

107 14691-14696.huda m. n. z. lewis k. m. kalanetra m. rashid s. m. ahmad r. raqib f. qadri m. a. underwood d. a. mills and c. b. stephensen.

nature 456 507-510.hansen c. h. d. s. nielsen m. kverka z. zakostelska k. klimesova t. hudcovic h. tlaskalova-hogenova and a. k. hansen.

elbein a. k. mehta a. aderem k. subbarao r. ahmed and b. pulendran.

95 149- 178.den b. g. e. k. van a. k. groen k. venema d. j. reijngoud and b. m. bakker.

pediatrics 134 e362-e372.lagos r. a. fasano s. s. wasserman v. prado m. o. sanp.

9 313-323.mazmanian s. k. c. h. liu a. o. tzianabos and d. l. kasper.

12 786-795.oh j. z. r. ravindran b. chassaing f. a. carvalho m. s. maddur m. bower p. hakimpour k. p. gill h. i. nakayaf.

180 1709-1712.reikie b. a. r. c. adams c. e. ruck k. ho a. leligdowiczs.

clarke d. l. topping m. tomita s. hori o. ohara t. morita h. koseki j. kikuchi k. honda k. hase and h. ohno.

short-chain fatty acids scfas are the end products of fermentation of dietary fibers by the anaerobic gut microbiota and have been shown to exert multiple beneficial effects on host immune homeostasis 13. for example butyrate-induced signaling inhibits histone deacetylases 14 increases the size and enhances the function of the colonic regulatory t cell pool 15. collectively microbiota-derived molecules including both bacterial components and metabolites influence the host immune function.based on the role of gut microbiota in development of the immune system it is logically expected that the microbiota may influence vaccine efficacy.

vaccine 21 138-145.grassly n. c. h. jafari s. bahl s. durrani j. wenger r.w.

